Author correction: co-delivery of docetaxel and silibinin using ph-sensitive micelles improves therapy of metastatic breast cancer

Correction to: Acta Pharmacol Sin https://doi.org/10.1038/aps.2017.74, published online 17 July 2017 The authors apologize that due to our neglect, in the initially published version of this

article, wrong images were pasted for the C6 group when doing the pictures layout of Fig. 3. Because the related text in the paper stated that “The free C6 exhibits a dim green

fluorescence, while CM displays a stronger fluorescence intensity” (page 1658, the left column, lines 8–17), and both the correct and the wrong images of the C6 group showed very weak

fluorescent intensity of coumarin-6, the arguments and conclusions of the original article are not affected. We apologize again for any inconvenience caused. The correct Fig. 3 is as follow:

AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Nano Science and Technology Institute, University of Science and Technology of China, Suzhou, 215123, China Xin-yue Dong * State Key Laboratory

of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China Tian-qun Lang, Qi Yin, Peng-cheng Zhang & 

Ya-ping Li Authors * Xin-yue Dong View author publications You can also search for this author inPubMed Google Scholar * Tian-qun Lang View author publications You can also search for this

author inPubMed Google Scholar * Qi Yin View author publications You can also search for this author inPubMed Google Scholar * Peng-cheng Zhang View author publications You can also search

for this author inPubMed Google Scholar * Ya-ping Li View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHORS Correspondence to Qi Yin or

Ya-ping Li. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Dong, Xy., Lang, Tq., Yin, Q. _et al._ Author Correction: Co-delivery of docetaxel and

silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer. _Acta Pharmacol Sin_ 40, 1258 (2019). https://doi.org/10.1038/s41401-019-0282-0 Download citation *

Published: 26 July 2019 * Issue Date: September 2019 * DOI: https://doi.org/10.1038/s41401-019-0282-0 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this

content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative